NORINYL Drug Patent Profile
✉ Email this page to a colleague
When do Norinyl patents expire, and when can generic versions of Norinyl launch?
Norinyl is a drug marketed by Actavis Labs Ut Inc, Allergan, and Gd Searle Llc. and is included in five NDAs.
The generic ingredient in NORINYL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORINYL?
- What are the global sales for NORINYL?
- What is Average Wholesale Price for NORINYL?
Summary for NORINYL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Drug Prices: | Drug price information for NORINYL |
| DailyMed Link: | NORINYL at DailyMed |
US Patents and Regulatory Information for NORINYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | NORINYL | mestranol; norethindrone | TABLET;ORAL-20 | 013625-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gd Searle Llc | NORINYL 1+80 28-DAY | mestranol; norethindrone | TABLET;ORAL-28 | 016725-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Actavis Labs Ut Inc | NORINYL 1+50 21-DAY | mestranol; norethindrone | TABLET;ORAL-21 | 013625-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | NORINYL 1+35 21-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 017565-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | NORINYL 1+35 28-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 017565-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
